Ketogenic Diet Linked to Reduced Symptoms in Schizophrenia and Bipolar Disorder, Study Finds
A clinical review suggests that ketogenic dietary therapy may help reduce psychiatric symptoms in patients with schizophrenia and bipolar disorder, though researchers call for larger trials.

A recent review of clinical evidence has found that the ketogenic diet, a high-fat, very low-carbohydrate eating plan, may help ease psychiatric symptoms in people with schizophrenia and bipolar disorder. Researchers say the findings add to a growing body of work linking metabolic health and brain function, while stopping short of recommending the diet as a standalone treatment.
What the Review Examined
The analysis pooled data from small pilot studies and case reports in which patients with serious mental illness adopted a ketogenic diet alongside standard psychiatric care. Across most reports, participants showed measurable improvements in mood stability, psychotic symptoms, and overall functioning once they reached nutritional ketosis, the metabolic state in which the body relies on fat-derived ketones instead of glucose for fuel.
Why Metabolism May Matter for the Brain
Scientists have long suspected that impaired glucose metabolism in certain brain regions contributes to the biology of psychotic and mood disorders. The ketogenic diet appears to restore an alternative energy pathway for neurons, which may in turn reduce inflammation and oxidative stress. Some researchers also note overlaps between the neurochemical effects of ketosis and those of mood stabilisers and antipsychotic medications, though the precise mechanisms remain under investigation.
Key Limitations
- Most included studies were small, open-label, or single-case designs.
- Adherence to a strict ketogenic regimen is difficult to maintain outside a clinical setting.
- Several patients were already taking psychiatric medications, making it hard to isolate the diet's independent effect.
Lead authors emphasised that the diet should be supervised by a clinical team, particularly for patients on medication, as ketosis can interact with drug metabolism. They are calling for randomised controlled trials to determine whether the benefits hold up in larger and more diverse populations. Readers interested in how dietary patterns intersect with neurological outcomes may also find relevant context in this overview of protein-focused nutrition and this report on metabolic therapies. Separately, lifestyle structure has been linked to physical health changes in this account of a structured fitness routine.